| 1 |
35370207 | Development of Low Molecular Weight Ligands for Integrin αvβ3. | 2022 |
1 |
| 2 |
35480387 | Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin αVβ3. | 2022 |
1 |
| 3 |
33803385 | Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp Cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific Delivery. | 2021 Mar 9 |
2 |
| 4 |
34356543 | Comparison of Linear vs. Cyclic RGD Pentapeptide Interactions with Integrin αvβ3 by Molecular Dynamics Simulations. | 2021 Jul 20 |
2 |
| 5 |
32451087 | Radioiodinated bicyclic RGD peptide for imaging integrin αvβ3 in cancers. | 2020 Jul 12 |
1 |
| 6 |
32612532 | Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells. | 2020 |
2 |
| 7 |
32655786 | Conjugation of arginylglycylaspartic acid to human serum albumin decreases the tumor-targeting effect of albumin by hindering its secreted protein acidic and rich in cysteine-mediated accumulation in tumors. | 2020 |
2 |
| 8 |
32688289 | Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy. | 2020 Sep-Oct |
1 |
| 9 |
30578136 | 68Ga-labelled NOTA-RGD-GE11 peptide for dual integrin and EGFR-targeted tumour imaging. | 2019 Jan - Feb |
1 |
| 10 |
30811704 | The Importance of Detail: How Differences in Ligand Structures Determine Distinct Functional Responses in Integrin αv β3. | 2019 Apr 23 |
1 |
| 11 |
31243977 | Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide. | 2019 Jul 17 |
1 |
| 12 |
31540828 | Preclinical evaluation of a dual sstr2 and integrin αvβ3-targeted heterodimer [68Ga]-NOTA-3PEG4-TATE-RGD. | 2019 Nov 1 |
2 |
| 13 |
31642677 | Construction of a Targeting Nanoparticle of 3',3″-Bis-Peptide-siRNA Conjugate/Mixed Lipid with Postinserted DSPE-PEG2000-cRGD. | 2019 Dec 2 |
1 |
| 14 |
28363829 | Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma. | 2017 Jun 15 |
1 |
| 15 |
26957261 | A new cyclic RGD peptide dimer for integrin αvβ3 imaging. | 2016 |
1 |
| 16 |
25647279 | A fluorescent Arg-Gly-Asp (RGD) peptide-naphthalenediimide (NDI) conjugate for imaging integrin α(v)β(3) in vitro. | 2015 Apr 25 |
1 |
| 17 |
24212468 | In vitro assessment of the dual-targeting behavior of a peptide-based magnetic resonance imaging contrast agent. | 2014 Jan |
1 |
| 18 |
25349221 | Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts? | 2014 Nov |
1 |
| 19 |
23708872 | 177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinoma. | 2013 Sep |
1 |
| 20 |
22248086 | Enhanced apoptosis-inducing function of MDA-7/IL-24 RGD mutant via the increased adhesion to tumor cells. | 2012 Feb |
1 |
| 21 |
21547159 | Integrin targeted delivery of chemotherapeutics. | 2011 Feb 17 |
1 |
| 22 |
19527117 | RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells. | 2009 Jul |
1 |
| 23 |
21136958 | Bioimaging of geographically adjacent proteins in a single cell by quantum dot-based fluorescent resonance energy transfer. | 2009 Dec |
2 |
| 24 |
18221059 | Integrin alpha v beta 3 antagonists for anti-angiogenic cancer treatment. | 2007 Jun |
1 |
| 25 |
15530369 | Structural insights into how the MIDAS ion stabilizes integrin binding to an RGD peptide under force. | 2004 Nov |
1 |
| 26 |
20641240 | 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-3-amino-(SCN-Bz-DOTA-111In)-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine | 2004 |
1 |
| 27 |
20641284 | Arginine-glycine-aspartic acid peptide-labeled quantum dot 705 | 2004 |
1 |
| 28 |
20641361 | 4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(S)-[N-3-amino-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine fluorescein thiourea | 2004 |
1 |
| 29 |
20641375 | N-[2-(4-[18F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid dimeric peptide | 2004 |
1 |
| 30 |
20641381 | Cy7-Tetrameric arginine-glycine-aspartic acid peptide | 2004 |
1 |
| 31 |
20641437 | [18F]FB-NH-mini-PEG-E{E[c(RGDyK)]2}2 | 2004 |
1 |
| 32 |
20641687 | 64Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-PEGylated dimeric cyclic arginine-glycine-aspartic acid peptide | 2004 |
1 |
| 33 |
20641766 | 64Cu-Anti-human integrin αvβ3 monoclonal antibody | 2004 |
1 |
| 34 |
11433393 | Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis. | 2001 Aug 1 |
1 |